Synopsis
Volvo s December sales in Europe dropped 1.8%, while China grew 9.9% and sales in the United States jumped 15.2%.
Agencies
STOCKHOLM: Car maker Volvo Cars said on Thursday its sales grew 6% in December, marking a continued sharp recovery from the lows earlier this year in the wake of the pandemic .
The company, owned by China s Geely Holding, said sales in the second half were the strongest in its history, while full-year sales dropped 6.2% to 661,713 cars. We had a great second half of the year after a tough start, gaining market share in all our main sales regions, Volvo s head of Global Commercial Operations, Lex Kerssemakers, said in a statement.
Car maker Volvo Cars said on Thursday its sales grew 6% in December, marking a continued sharp recovery from the lows earlier this year in the wake of the pandemic .
Search jobs FDA Approves Amgen s RIABNI(TM) (rituximab-arrx), A Biosimilar To Rituxan® (rituximab)
THOUSAND OAKS, Calif., Dec. 17, 2020 /PRNewswire/ Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved RIABNI™ (rituximab-arrx), a biosimilar to Rituxan
® (rituximab), for the treatment of adult patients with Non-Hodgkin s Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Granulomatosis with Polyangiitis (GPA) (Wegener s Granulomatosis), and Microscopic Polyangiitis (MPA). RIABNI will be made available in the U.S. in January 2021. The approval of RIABNI represents an important milestone across our biosimilar and oncology portfolios, said Murdo Gordon, executive vice president of Global Commercial Operations at Amgen. Following the proven success of KANJINTI